Emergency Use Authorizations (euas) - Vaccines

Relevant Publications

Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19.

Issue Release: 2024

Health Equity and Access to COVID-19 Treatments Available through Emergency Use Authorizations.

Issue Release: 2024

Advancements in SARS-CoV-2 detection: Navigating the molecular landscape and diagnostic technologies.

Issue Release: 2024

Clinical Evaluation of BioFire COVID-19 Test, BioFire Respiratory Panel 2.1, and Cepheid Xpert Xpress SARS-CoV-2 Assays for Sample-to-Answer Detection of SARS-CoV-2.

Issue Release: 2023

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.

Issue Release: 2023

The evidence base for emergency use authorizations for COVID-19 treatments: A rapid review.

Issue Release: 2023

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.

Issue Release: 2023

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.

Issue Release: 2023

Fair Allocation of Scarce Therapies for Coronavirus Disease 2019 (COVID-19).

Issue Release: 2022

An updated review of SARS-CoV-2 detection methods in the context of a novel coronavirus pandemic.

Issue Release: 2022

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords.

Issue Release: 2022

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies.

Issue Release: 2022

Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents.

Issue Release: 2022

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Issue Release: 2022

The clinical progress of mRNA vaccines and immunotherapies.

Issue Release: 2022

PD-LAMP smartphone detection of SARS-CoV-2 on chip.

Issue Release: 2022

Immunomodulatory therapies for COVID-19.

Issue Release: 2022

RxLegal: Emergency Use Authorizations.

Issue Release: 2022

A systematic review comparing at-home diagnostic tests for SARS-CoV-2: Key points for pharmacy practice, including regulatory information.

Issue Release: 2021

Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.

Issue Release: 2021

What is the Hepatitis B Vaccine?

Can Vaccines Overload the Immune System?

What is HBV DNA?

Are There Side Effects to Vaccines?

Is Oseltamivir Effective Against New Strains?

How is Measles Surveillance Conducted?

What is a Pandemic?

Is There an Optimal Type of Exercise for Enhancing Vaccine Response?

When Should Newborns Receive Vaccinations?

What Are the Common Misconceptions About Vaccines?

Partnered Content Networks

Relevant Topics